LGALS3 and in situ carcinoma: The CIS-treated Gal-3 wild-type group showed ATN involving 51.98% ± 6.57% of renal parenchyma (Figure 2I) with athe loss of brush borders, swelling of tubular cells, intratubular falling cells, and intratubular secretions (Figure 2C,D).